RNS Number : 2291K
Induction Healthcare Group PLC
20 December 2022
 

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Change of Auditor

 

Induction (AIM: INHC), a leading digital health platform driving transformation of healthcare systems worldwide, announces that following a competitive and comprehensive tender process, Crowe U.K. LLP will be appointed as the Company's auditor for the year ending 31 March 2023. The Company intends to put the appointment of Crowe U.K. LLP as auditor to a vote of shareholders at the Company's next Annual General Meeting.

 

KPMG LLP, the Company's current auditor, will cease to hold office as the Group's auditor when the present term of office expires at the conclusion of the Company's 2023 AGM. KPMG LLP has confirmed that there are no matters connected with it ceasing to hold office that should be brought to the attention of the members or creditors of the Company. 

 

ENQUIRIES

 

Induction

James Balmain, Chief Executive Officer

Christopher Samler, Non-Executive Chair

Via Walbrook PR Ltd: induction@walbrookpr.com



Singer Capital Markets (Nominated Adviser and Broker)

+44 (0)20 7496 3000

Philip Davies / Kailey Aliyar




Walbrook PR Ltd 

induction@walbrookpr.com

Alice Woodings / Paul McManus

Mob: +44 (0)7407 804 654 / +44(0)7980 541 893

 

About Induction - www.inductionhealthcare.com

Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - giving the communities they serve greater flexibility, control and ease of access. Purpose-built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.

 

Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPZZMMZNLKGZZM